Wang Xia, Arima Hisatomi, Al-Shahi Salman Rustam, Woodward Mark, Heeley Emma, Stapf Christian, Lavados Pablo M, Robinson Thompson, Huang Yining, Wang Jiguang, Delcourt Candice, Anderson Craig S
The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia.
Cerebrovasc Dis. 2015;39(3-4):242-8. doi: 10.1159/000381107. Epub 2015 Mar 25.
Early intensive blood pressure (BP) lowering has been shown to improve functional outcome in acute intracerebral hemorrhage (ICH), but the treatment effect is modest and without a clearly defined underlying explanatory mechanism. We aimed at more reliably quantifying the benefits of this treatment according to different time periods in the recovery of participants in the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT) studies.
Pooled analysis of the pilot INTERACT1 (n = 404) and main INTERACT2 (n = 2,839) involving patients with spontaneous ICH (<6 h) and elevated systolic BP (SBP 150-220 mm Hg) who were randomized to intensive (target SBP <140 mm Hg) or guideline-recommended (target SBP <180 mm Hg) BP lowering treatment. Treatment effects were examined according to repeated measures analysis of an ordinal ('shift') across all 7 levels of the modified Rankin Scale (mRS) assessed during follow-up at 7, 28, and 90 days, post-randomization.
http://www.clinicaltrials.gov, NCT00226096 and NCT00716079.
Intensive BP lowering resulted in a significant favorable distribution of mRS scores for better functioning (odds ratio 1.13, 95% confidence interval 1.00-1.26; p = 0.042) over 7, 28 and 90 days, and the effect was consistency for early (7-28 days) and later (28-90 days) time periods (p homogeneity 0.353). Treatment effects were also consistent across several pre-specified patient characteristic subgroups, with trends favoring those randomized early, and with higher SBP and milder neurological severity at baseline.
Intensive BP lowering provides beneficial effects on physical functioning that manifests consistently through the early and later phases of recovery from ICH.
早期强化降压已被证明可改善急性脑出血(ICH)患者的功能预后,但治疗效果有限,且尚无明确的潜在解释机制。我们旨在根据急性脑出血强化降压试验(INTERACT)研究中参与者恢复的不同时间段,更可靠地量化这种治疗的益处。
对INTERACT1试验(n = 404)和主要的INTERACT2试验(n = 2839)进行汇总分析,纳入自发性ICH(<6小时)且收缩压(SBP)升高(150 - 220 mmHg)的患者,这些患者被随机分为强化降压组(目标SBP <140 mmHg)或指南推荐的降压组(目标SBP <180 mmHg)。根据随机分组后7天、28天和90天随访期间评估的改良Rankin量表(mRS)所有7个等级的有序(“移位”)重复测量分析来检验治疗效果。
http://www.clinicaltrials.gov,NCT00226096和NCT00716079。
强化降压导致在7天、28天和90天期间mRS评分向更好功能的显著有利分布(优势比1.13,95%置信区间1.00 - 1.26;p = 0.042),并且在早期(7 - 28天)和后期(28 - 90天)时间段效果一致(p同质性0.353)。治疗效果在几个预先指定的患者特征亚组中也一致,趋势有利于早期随机分组的患者,以及基线时SBP较高和神经功能缺损较轻的患者。
强化降压对身体功能有有益影响,在ICH恢复的早期和后期阶段均持续显现。